The Latest Breaking News from FDA

FDA sends more than 100 warning letters to firms over new synthetic nicotine law

The FDA has vowed to take more action in the coming weeks.

Axios · Jul 14, 2022

Gateshead's Shield Therapeutics awaits Canadian regulatory approval for iron deficiency drug

The pharmaceutical firm says Health Canada will screen its Accrufer lead product, with an outcome expected next year

Birmingham Post · Jul 14, 2022

Novavax’s COVID vaccine gets US nod as latest pandemic weapon

Novavax Inc.’s COVID-19 vaccine was cleared by U.S. regulators, giving Americans another tool against the virus as cases start to rise again.

Tribune News Service · Jul 13, 2022

PharmaTher Receives Notice Of Allowance For U.S. Patent Covering Ketamine For Parkinson's And Motor Disorders Treatment

Ketamine pharmaceuticals provider PharmaTher Holdings Ltd. (OTCQB: PHRRF) has been granted a Notice of Allowance by the U.S.

Benzinga · Jul 13, 2022

Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Benzinga · Jul 13, 2022

Science Wednesday: Where To See Comet K2 As It Passes The Earth

Five years ago, astronomers were electrified to confirm the discovery of Comet C/2017 K2, more commonly known as Comet K2. At the time, it was believed to be one of the largest comets zooming across the universe, with a nucleus believed to be around 11 miles in diameter and a…

Benzinga · Jul 13, 2022

Poll: Only 26 Percent of Democrats Want Biden To Run in 2024

Plus: Psilocybin microdosing improves mood, vaping regulations backfire, and more...

Reason · Jul 13, 2022

Inhale Success: Blakk Tatted Becomes Overnight Millionaire With Hookah Brand

NEW ORLEANS — Blakk Tatted loves the idea of being an overnight success.

Zenger · Jul 13, 2022

Will Americans have the right COVID-19 vaccine this fall? Maybe

In a few short months, the weather will turn crisp, the holiday season will draw near, and the coronavirus may embark on its third consecutive winter of death and devastation.

Los Angeles Times · Jul 13, 2022

Boeing, PriceSmart And 80 Biggest Movers From Yesterday

Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.

Benzinga · Jul 13, 2022